Today: 19 March 2026
Browse Category

NASDAQ:IBO 17 January 2026

ImmunityBio stock set for volatile week after ANKTIVA sales jump and new trial update

ImmunityBio stock set for volatile week after ANKTIVA sales jump and new trial update

ImmunityBio shares surged 39.8% Friday after reporting a 750% jump in 2025 ANKTIVA sales and new regulatory approvals, including in Saudi Arabia. The company said its pivotal bladder cancer trial is over 85% enrolled, with completion targeted for Q2 2026. ImmunityBio ended the quarter with $242.8 million in cash. Investors await audited 2025 results and further updates on ANKTIVA and CAR-NK programs.

Stock Market Today

  • Sensex Drops 2,500 Points Amid Rising Crude Prices and Geopolitical Tensions
    March 19, 2026, 4:54 PM EDT. India's Sensex plunged over 2,490 points (3.26%), settling at 74,207 amid a surge in crude oil prices and escalating geopolitical tensions between the US, Israel, and Iran. The Nifty also slipped 775 points to 23,002. Rising crude prices-Brent crude rose 3.77% to $111.4 per barrel-fueled fears of inflation and supply disruptions, exacerbated by Iran's attacks on Gulf energy infrastructure. Major index losers included HDFC Bank and Shriram Finance, while Oil and Natural Gas Corporation (ONGC) and Reliance Industries gained. Foreign institutional investors continued selling pressure. Meanwhile, silver and gold prices tumbled sharply, with silver down 7% and gold by 4.37%, pressured by global selloffs. Market sentiment remains fragile amid heightened uncertainty and inflation fears impacting global and Indian financial markets.
Go toTop